Copyright Reports & Markets. All rights reserved.

Global Ambulatory Cardiac Monitoring Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Ambulatory Cardiac Monitoring Devices Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Holter Monitor
    • 1.3.3 Event Monitor
    • 1.3.4 Mobile Cardiac Telemetry
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Ambulatory Cardiac Monitoring Devices Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals
    • 1.4.3 Ambulatory Care Centers
    • 1.4.4 Others
  • 1.5 Global Ambulatory Cardiac Monitoring Devices Market Size & Forecast
    • 1.5.1 Global Ambulatory Cardiac Monitoring Devices Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Ambulatory Cardiac Monitoring Devices Sales Quantity (2021-2032)
    • 1.5.3 Global Ambulatory Cardiac Monitoring Devices Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Medtronic
    • 2.1.1 Medtronic Details
    • 2.1.2 Medtronic Major Business
    • 2.1.3 Medtronic Ambulatory Cardiac Monitoring Devices Product and Services
    • 2.1.4 Medtronic Ambulatory Cardiac Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Medtronic Recent Developments/Updates
  • 2.2 Abbott
    • 2.2.1 Abbott Details
    • 2.2.2 Abbott Major Business
    • 2.2.3 Abbott Ambulatory Cardiac Monitoring Devices Product and Services
    • 2.2.4 Abbott Ambulatory Cardiac Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Abbott Recent Developments/Updates
  • 2.3 GE Healthcare
    • 2.3.1 GE Healthcare Details
    • 2.3.2 GE Healthcare Major Business
    • 2.3.3 GE Healthcare Ambulatory Cardiac Monitoring Devices Product and Services
    • 2.3.4 GE Healthcare Ambulatory Cardiac Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 GE Healthcare Recent Developments/Updates
  • 2.4 Philips Healthcare
    • 2.4.1 Philips Healthcare Details
    • 2.4.2 Philips Healthcare Major Business
    • 2.4.3 Philips Healthcare Ambulatory Cardiac Monitoring Devices Product and Services
    • 2.4.4 Philips Healthcare Ambulatory Cardiac Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Philips Healthcare Recent Developments/Updates
  • 2.5 Hill-Rom
    • 2.5.1 Hill-Rom Details
    • 2.5.2 Hill-Rom Major Business
    • 2.5.3 Hill-Rom Ambulatory Cardiac Monitoring Devices Product and Services
    • 2.5.4 Hill-Rom Ambulatory Cardiac Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Hill-Rom Recent Developments/Updates
  • 2.6 Medicomp
    • 2.6.1 Medicomp Details
    • 2.6.2 Medicomp Major Business
    • 2.6.3 Medicomp Ambulatory Cardiac Monitoring Devices Product and Services
    • 2.6.4 Medicomp Ambulatory Cardiac Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Medicomp Recent Developments/Updates
  • 2.7 Schiller
    • 2.7.1 Schiller Details
    • 2.7.2 Schiller Major Business
    • 2.7.3 Schiller Ambulatory Cardiac Monitoring Devices Product and Services
    • 2.7.4 Schiller Ambulatory Cardiac Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Schiller Recent Developments/Updates
  • 2.8 Spacelabs Healthcare
    • 2.8.1 Spacelabs Healthcare Details
    • 2.8.2 Spacelabs Healthcare Major Business
    • 2.8.3 Spacelabs Healthcare Ambulatory Cardiac Monitoring Devices Product and Services
    • 2.8.4 Spacelabs Healthcare Ambulatory Cardiac Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Spacelabs Healthcare Recent Developments/Updates
  • 2.9 Applied Cardiac Systems
    • 2.9.1 Applied Cardiac Systems Details
    • 2.9.2 Applied Cardiac Systems Major Business
    • 2.9.3 Applied Cardiac Systems Ambulatory Cardiac Monitoring Devices Product and Services
    • 2.9.4 Applied Cardiac Systems Ambulatory Cardiac Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Applied Cardiac Systems Recent Developments/Updates
  • 2.10 iRhythm
    • 2.10.1 iRhythm Details
    • 2.10.2 iRhythm Major Business
    • 2.10.3 iRhythm Ambulatory Cardiac Monitoring Devices Product and Services
    • 2.10.4 iRhythm Ambulatory Cardiac Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 iRhythm Recent Developments/Updates
  • 2.11 Bio Telemetry
    • 2.11.1 Bio Telemetry Details
    • 2.11.2 Bio Telemetry Major Business
    • 2.11.3 Bio Telemetry Ambulatory Cardiac Monitoring Devices Product and Services
    • 2.11.4 Bio Telemetry Ambulatory Cardiac Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Bio Telemetry Recent Developments/Updates
  • 2.12 Medicalgorithmics
    • 2.12.1 Medicalgorithmics Details
    • 2.12.2 Medicalgorithmics Major Business
    • 2.12.3 Medicalgorithmics Ambulatory Cardiac Monitoring Devices Product and Services
    • 2.12.4 Medicalgorithmics Ambulatory Cardiac Monitoring Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Medicalgorithmics Recent Developments/Updates

3 Competitive Environment: Ambulatory Cardiac Monitoring Devices by Manufacturer

  • 3.1 Global Ambulatory Cardiac Monitoring Devices Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Ambulatory Cardiac Monitoring Devices Revenue by Manufacturer (2021-2026)
  • 3.3 Global Ambulatory Cardiac Monitoring Devices Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Ambulatory Cardiac Monitoring Devices by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Ambulatory Cardiac Monitoring Devices Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Ambulatory Cardiac Monitoring Devices Manufacturer Market Share in 2025
  • 3.5 Ambulatory Cardiac Monitoring Devices Market: Overall Company Footprint Analysis
    • 3.5.1 Ambulatory Cardiac Monitoring Devices Market: Region Footprint
    • 3.5.2 Ambulatory Cardiac Monitoring Devices Market: Company Product Type Footprint
    • 3.5.3 Ambulatory Cardiac Monitoring Devices Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ambulatory Cardiac Monitoring Devices Market Size by Region
    • 4.1.1 Global Ambulatory Cardiac Monitoring Devices Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Ambulatory Cardiac Monitoring Devices Consumption Value by Region (2021-2032)
    • 4.1.3 Global Ambulatory Cardiac Monitoring Devices Average Price by Region (2021-2032)
  • 4.2 North America Ambulatory Cardiac Monitoring Devices Consumption Value (2021-2032)
  • 4.3 Europe Ambulatory Cardiac Monitoring Devices Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Ambulatory Cardiac Monitoring Devices Consumption Value (2021-2032)
  • 4.5 South America Ambulatory Cardiac Monitoring Devices Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Ambulatory Cardiac Monitoring Devices Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Ambulatory Cardiac Monitoring Devices Sales Quantity by Type (2021-2032)
  • 5.2 Global Ambulatory Cardiac Monitoring Devices Consumption Value by Type (2021-2032)
  • 5.3 Global Ambulatory Cardiac Monitoring Devices Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Ambulatory Cardiac Monitoring Devices Sales Quantity by Application (2021-2032)
  • 6.2 Global Ambulatory Cardiac Monitoring Devices Consumption Value by Application (2021-2032)
  • 6.3 Global Ambulatory Cardiac Monitoring Devices Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Ambulatory Cardiac Monitoring Devices Sales Quantity by Type (2021-2032)
  • 7.2 North America Ambulatory Cardiac Monitoring Devices Sales Quantity by Application (2021-2032)
  • 7.3 North America Ambulatory Cardiac Monitoring Devices Market Size by Country
    • 7.3.1 North America Ambulatory Cardiac Monitoring Devices Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Ambulatory Cardiac Monitoring Devices Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Ambulatory Cardiac Monitoring Devices Sales Quantity by Type (2021-2032)
  • 8.2 Europe Ambulatory Cardiac Monitoring Devices Sales Quantity by Application (2021-2032)
  • 8.3 Europe Ambulatory Cardiac Monitoring Devices Market Size by Country
    • 8.3.1 Europe Ambulatory Cardiac Monitoring Devices Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Ambulatory Cardiac Monitoring Devices Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ambulatory Cardiac Monitoring Devices Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Ambulatory Cardiac Monitoring Devices Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Ambulatory Cardiac Monitoring Devices Market Size by Region
    • 9.3.1 Asia-Pacific Ambulatory Cardiac Monitoring Devices Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Ambulatory Cardiac Monitoring Devices Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Ambulatory Cardiac Monitoring Devices Sales Quantity by Type (2021-2032)
  • 10.2 South America Ambulatory Cardiac Monitoring Devices Sales Quantity by Application (2021-2032)
  • 10.3 South America Ambulatory Cardiac Monitoring Devices Market Size by Country
    • 10.3.1 South America Ambulatory Cardiac Monitoring Devices Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Ambulatory Cardiac Monitoring Devices Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ambulatory Cardiac Monitoring Devices Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Ambulatory Cardiac Monitoring Devices Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Ambulatory Cardiac Monitoring Devices Market Size by Country
    • 11.3.1 Middle East & Africa Ambulatory Cardiac Monitoring Devices Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Ambulatory Cardiac Monitoring Devices Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Ambulatory Cardiac Monitoring Devices Market Drivers
  • 12.2 Ambulatory Cardiac Monitoring Devices Market Restraints
  • 12.3 Ambulatory Cardiac Monitoring Devices Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ambulatory Cardiac Monitoring Devices and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ambulatory Cardiac Monitoring Devices
  • 13.3 Ambulatory Cardiac Monitoring Devices Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ambulatory Cardiac Monitoring Devices Typical Distributors
  • 14.3 Ambulatory Cardiac Monitoring Devices Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Ambulatory Cardiac Monitoring Devices market size was valued at US$ 1130 million in 2025 and is forecast to a readjusted size of US$ 1542 million by 2032 with a CAGR of 4.6% during review period.
    Ambulatory Cardiac Monitoring Devices refer to wearable or implantable devices designed to continuously or intermittently monitor the heart’s electrophysiological activity outside fixed medical environments, often over extended periods. Their purpose is to detect cardiac anomalies such as arrhythmias, atrial fibrillation, bradycardia, and tachycardia that are not easily captured during brief or static examinations. These devices typically include electrode or lead systems, signal transmission or storage units, data analysis modules (including remote or cloud infrastructure), and may integrate mobile communication, wireless technologies, and AI-driven analytics to enhance detection sensitivity and user convenience. Use cases span in-hospital monitoring, outpatient/ambulatory care, home healthcare, and remote health management, making them essential tools in cardiovascular disease management and prevention of adverse cardiac events.In 2024, global Ambulatory Cardiac Monitoring Device production reached approximately 1171 k units, with an average global market price of around US$ 900 perunit.
    With accelerating global population ageing and rising incidence of chronic cardiovascular diseases (such as atrial fibrillation, arrhythmias, and hypertension-induced cardiac stress), there is a growing demand for preventive monitoring and early diagnosis. Governments in many countries have made chronic disease management, public health policy, and healthcare innovation—including remote medicine, digital health, localized medical device innovation—core priorities. Policies and subsidies nurture remote cardiac monitoring adoption; national health plans such as “Healthy China 2030” in China, U.S./EU medical reform programs emphasize early screening and remote care. Technologically, advances in wireless transmission, continuous monitoring (wearable, multi-lead, MEMS electrodes, biosensors), implantable or patch-type designs, and AI/ML algorithms for signal processing and prediction have significantly improved accuracy, comfort, portability, and user experience. Acceptance of wearable, remote, home monitoring devices is rapidly rising. Manufacturing and supply chain, benefitting from economies of scale and widespread electronics/materials supply, are seeing cost declines, improving margins, and attracting investment from venture capital, private equity, and established med-tech firms.Despite great potential, the industry faces several significant challenges. Firstly, regulatory and compliance barriers are high: different countries/regions require stringent safety, clinical validation, and certification procedures, which take time and cost, especially burdening small-to-medium enterprises. Secondly, privacy & data security risks: continuous monitoring involves sensitive physiological data transmitted wirelessly or stored in the cloud; encryption, compliance (e.g. GDPR, HIPAA, national laws) must be rigorous, and breaches can damage trust and incur legal liability. Third, user acceptability and comfort: wearable/patch devices may cause skin irritation, discomfort, limited battery life, motion/sweat/environment noise interference; implantable devices involve surgical risk and higher cost. Fourth, the high cost of high-end innovative technologies and R&D: if reimbursement or insurance systems do not cover these devices, adoption will be constrained. Also, in low-/middle-income countries, limited healthcare infrastructure and lower purchasing power restrict market penetration.Downstream demand is trending toward greater diversity, personalization, and integration. Home care and at-home medical monitoring are major growth areas, particularly after the COVID-19 pandemic normalized remote healthcare; patients and families prefer portable, user-friendly, connected devices. Hospitals and diagnostic centers increasingly demand “real-time monitoring + data-analytics + remote reporting”, with seamless integration into hospital information systems (HIS), electronic medical records (EMR), and telehealth platforms, to reduce manual review, improve accuracy, speed of response. Another trend is the business model “hardware + software + services”: beyond the device itself, value-added services (data interpretation, report generation, arrhythmia prediction / early warnings) are becoming competitive differentiators. Growing insurance / reimbursement coverage also amplifies demand strength. Among younger populations, high acceptance of wearable health devices drives demand for preventive ECG monitoring, heart rate variability monitoring during exercise, etc.
    This report is a detailed and comprehensive analysis for global Ambulatory Cardiac Monitoring Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Ambulatory Cardiac Monitoring Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
    Global Ambulatory Cardiac Monitoring Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
    Global Ambulatory Cardiac Monitoring Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2021-2032
    Global Ambulatory Cardiac Monitoring Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Ambulatory Cardiac Monitoring Devices
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Ambulatory Cardiac Monitoring Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Abbott, GE Healthcare, Philips Healthcare, Hill-Rom, Medicomp, Schiller, Spacelabs Healthcare, Applied Cardiac Systems, iRhythm, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Ambulatory Cardiac Monitoring Devices market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Holter Monitor
    Event Monitor
    Mobile Cardiac Telemetry
    Others
    Market segment by Application
    Hospitals
    Ambulatory Care Centers
    Others
    Major players covered
    Medtronic
    Abbott
    GE Healthcare
    Philips Healthcare
    Hill-Rom
    Medicomp
    Schiller
    Spacelabs Healthcare
    Applied Cardiac Systems
    iRhythm
    Bio Telemetry
    Medicalgorithmics
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Ambulatory Cardiac Monitoring Devices product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Ambulatory Cardiac Monitoring Devices, with price, sales quantity, revenue, and global market share of Ambulatory Cardiac Monitoring Devices from 2021 to 2026.
    Chapter 3, the Ambulatory Cardiac Monitoring Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Ambulatory Cardiac Monitoring Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ambulatory Cardiac Monitoring Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Ambulatory Cardiac Monitoring Devices.
    Chapter 14 and 15, to describe Ambulatory Cardiac Monitoring Devices sales channel, distributors, customers, research findings and conclusion.

    Buy now